October 27, 2020 Project deliverable Open Access

Miceli, Rosalba

Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Miceli, Rosalba</dc:creator>
  <dc:date>2020-10-27</dc:date>
  <dc:description>https://gdefiner.net/ 

Project: "Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment" 

(G-DEFINER). 

Clinical study CRFs. (DOI of the Study Protocol: 10.5281/zenodo.4142124)

This is a multicenter observational prospective clinical study aimed at investigating the inequalities between female (F) and male (M) patients in the development of immune-related adverse events (irAEs) associated with immunotherapy treatment. The evaluation of the differences in terms of irAEs incidence concerning biological aspects will be integrated by the exploration of their gender dimension.</dc:description>
  <dc:identifier>https://zenodo.org/record/4142787</dc:identifier>
  <dc:identifier>10.5281/zenodo.4142787</dc:identifier>
  <dc:identifier>oai:zenodo.org:4142787</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/grantAgreement/EC/H2020/741874/</dc:relation>
  <dc:relation>doi:10.5281/zenodo.4142786</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/legalcode</dc:rights>
  <dc:subject>Clinical Oncology, Immunotherapy,  Sex, Gender, Biology, Biostatistics. Bioinformatics</dc:subject>
  <dc:title>G-DEFINER  CRFs</dc:title>
  <dc:type>info:eu-repo/semantics/report</dc:type>
  <dc:type>publication-deliverable</dc:type>
</oai_dc:dc>